Dexfadrostat

DB21746InvestigationalSmall molecule

Dexfadrostat is under investigation in clinical trial NCT04007406 (DP13 - a Phase II Study in Patients With Primary Aldosteronism).

Chemical structure of Dexfadrostat
Formula / weight
C14H13N3 · 223.279 g/mol (avg)

Resolves to

Compound
UNIIIC1B8751F6CAS102676-87-9ChEMBLCHEMBL287677ChEBI748096PubChem9815923
Structure
InChIKeyCLPFFLWZZBQMAO-CQSZACIVSA-NSMILESN#CC1=CC=C(C=C1)[C@H]1CCCC2=CN=CN12
Targets
P15538CYP11B1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexfadrostat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In